Global Radiopharmaceuticals for Therapeutic Supply, Demand and Key Producers, 2023-2029

Description

The global Radiopharmaceuticals for Therapeutic market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.

This report studies the global Radiopharmaceuticals for Therapeutic demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Radiopharmaceuticals for Therapeutic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Radiopharmaceuticals for Therapeutic that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Radiopharmaceuticals for Therapeutic total market, 2018-2029, (USD Million)
Global Radiopharmaceuticals for Therapeutic total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Radiopharmaceuticals for Therapeutic total market, key domestic companies and share, (USD Million)
Global Radiopharmaceuticals for Therapeutic revenue by player and market share 2018-2023, (USD Million)
Global Radiopharmaceuticals for Therapeutic total market by Type, CAGR, 2018-2029, (USD Million)
Global Radiopharmaceuticals for Therapeutic total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Radiopharmaceuticals for Therapeutic market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Lantheus and Spectrum Pharmaceuticals, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Radiopharmaceuticals for Therapeutic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Radiopharmaceuticals for Therapeutic Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Radiopharmaceuticals for Therapeutic Market, Segmentation by Type
    Radium-223
    Lutetium-177
    Iodine-131
    Other

Global Radiopharmaceuticals for Therapeutic Market, Segmentation by Application
    Thyroid
    Bone Metastasis
    Lymphoma
    Other

Companies Profiled:
    Bayer
    Novartis
    China Isotope & Radiation
    Dongcheng
    Q BioMed
    Curium Pharmaceuticals
    Jubilant DraxImage
    Lantheus
    Spectrum Pharmaceuticals
    Progenics Pharmaceuticals
    International Isotopes

Key Questions Answered
1. How big is the global Radiopharmaceuticals for Therapeutic market?
2. What is the demand of the global Radiopharmaceuticals for Therapeutic market?
3. What is the year over year growth of the global Radiopharmaceuticals for Therapeutic market?
4. What is the total value of the global Radiopharmaceuticals for Therapeutic market?
5. Who are the major players in the global Radiopharmaceuticals for Therapeutic market?
6. What are the growth factors driving the market demand?

Table of Contents

1 Supply Summary
    1.1 Radiopharmaceuticals for Therapeutic Introduction
    1.2 World Radiopharmaceuticals for Therapeutic Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World Radiopharmaceuticals for Therapeutic Total Market by Region (by Headquarter Location)
        1.3.1 World Radiopharmaceuticals for Therapeutic Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
        1.3.3 China Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
        1.3.4 Europe Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
        1.3.5 Japan Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
        1.3.6 South Korea Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
        1.3.7 ASEAN Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
        1.3.8 India Radiopharmaceuticals for Therapeutic Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Radiopharmaceuticals for Therapeutic Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Radiopharmaceuticals for Therapeutic Major Market Trends
    1.5 Influence of COVID-19 and Russia-Ukraine War
        1.5.1 Influence of COVID-19
        1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
    2.1 World Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029)
    2.2 World Radiopharmaceuticals for Therapeutic Consumption Value by Region
        2.2.1 World Radiopharmaceuticals for Therapeutic Consumption Value by Region (2018-2023)
        2.2.2 World Radiopharmaceuticals for Therapeutic Consumption Value Forecast by Region (2024-2029)
    2.3 United States Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029)
    2.4 China Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029)
    2.5 Europe Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029)
    2.6 Japan Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029)
    2.7 South Korea Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029)
    2.8 ASEAN Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029)
    2.9 India Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029)

3 World Radiopharmaceuticals for Therapeutic Companies Competitive Analysis
    3.1 World Radiopharmaceuticals for Therapeutic Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Radiopharmaceuticals for Therapeutic Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Radiopharmaceuticals for Therapeutic in 2022
        3.2.3 Global Concentration Ratios (CR8) for Radiopharmaceuticals for Therapeutic in 2022
    3.3 Radiopharmaceuticals for Therapeutic Company Evaluation Quadrant
    3.4 Radiopharmaceuticals for Therapeutic Market: Overall Company Footprint Analysis
        3.4.1 Radiopharmaceuticals for Therapeutic Market: Region Footprint
        3.4.2 Radiopharmaceuticals for Therapeutic Market: Company Product Type Footprint
        3.4.3 Radiopharmaceuticals for Therapeutic Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Radiopharmaceuticals for Therapeutic Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Radiopharmaceuticals for Therapeutic Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: Radiopharmaceuticals for Therapeutic Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: Radiopharmaceuticals for Therapeutic Consumption Value Comparison
        4.2.1 United States VS China: Radiopharmaceuticals for Therapeutic Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Radiopharmaceuticals for Therapeutic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based Radiopharmaceuticals for Therapeutic Companies and Market Share, 2018-2023
        4.3.1 United States Based Radiopharmaceuticals for Therapeutic Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Radiopharmaceuticals for Therapeutic Revenue, (2018-2023)
    4.4 China Based Companies Radiopharmaceuticals for Therapeutic Revenue and Market Share, 2018-2023
        4.4.1 China Based Radiopharmaceuticals for Therapeutic Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Radiopharmaceuticals for Therapeutic Revenue, (2018-2023)
    4.5 Rest of World Based Radiopharmaceuticals for Therapeutic Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based Radiopharmaceuticals for Therapeutic Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Radiopharmaceuticals for Therapeutic Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World Radiopharmaceuticals for Therapeutic Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Radium-223
        5.2.2 Lutetium-177
        5.2.3 Iodine-131
        5.2.4 Other
    5.3 Market Segment by Type
        5.3.1 World Radiopharmaceuticals for Therapeutic Market Size by Type (2018-2023)
        5.3.2 World Radiopharmaceuticals for Therapeutic Market Size by Type (2024-2029)
        5.3.3 World Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Radiopharmaceuticals for Therapeutic Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Thyroid
        6.2.2 Bone Metastasis
        6.2.3 Lymphoma
        6.2.4 Other
        6.2.5 Other
    6.3 Market Segment by Application
        6.3.1 World Radiopharmaceuticals for Therapeutic Market Size by Application (2018-2023)
        6.3.2 World Radiopharmaceuticals for Therapeutic Market Size by Application (2024-2029)
        6.3.3 World Radiopharmaceuticals for Therapeutic Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Bayer
        7.1.1 Bayer Details
        7.1.2 Bayer Major Business
        7.1.3 Bayer Radiopharmaceuticals for Therapeutic Product and Services
        7.1.4 Bayer Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Bayer Recent Developments/Updates
        7.1.6 Bayer Competitive Strengths & Weaknesses
    7.2 Novartis
        7.2.1 Novartis Details
        7.2.2 Novartis Major Business
        7.2.3 Novartis Radiopharmaceuticals for Therapeutic Product and Services
        7.2.4 Novartis Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Novartis Recent Developments/Updates
        7.2.6 Novartis Competitive Strengths & Weaknesses
    7.3 China Isotope & Radiation
        7.3.1 China Isotope & Radiation Details
        7.3.2 China Isotope & Radiation Major Business
        7.3.3 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product and Services
        7.3.4 China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 China Isotope & Radiation Recent Developments/Updates
        7.3.6 China Isotope & Radiation Competitive Strengths & Weaknesses
    7.4 Dongcheng
        7.4.1 Dongcheng Details
        7.4.2 Dongcheng Major Business
        7.4.3 Dongcheng Radiopharmaceuticals for Therapeutic Product and Services
        7.4.4 Dongcheng Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 Dongcheng Recent Developments/Updates
        7.4.6 Dongcheng Competitive Strengths & Weaknesses
    7.5 Q BioMed
        7.5.1 Q BioMed Details
        7.5.2 Q BioMed Major Business
        7.5.3 Q BioMed Radiopharmaceuticals for Therapeutic Product and Services
        7.5.4 Q BioMed Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 Q BioMed Recent Developments/Updates
        7.5.6 Q BioMed Competitive Strengths & Weaknesses
    7.6 Curium Pharmaceuticals
        7.6.1 Curium Pharmaceuticals Details
        7.6.2 Curium Pharmaceuticals Major Business
        7.6.3 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Services
        7.6.4 Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Curium Pharmaceuticals Recent Developments/Updates
        7.6.6 Curium Pharmaceuticals Competitive Strengths & Weaknesses
    7.7 Jubilant DraxImage
        7.7.1 Jubilant DraxImage Details
        7.7.2 Jubilant DraxImage Major Business
        7.7.3 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Product and Services
        7.7.4 Jubilant DraxImage Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Jubilant DraxImage Recent Developments/Updates
        7.7.6 Jubilant DraxImage Competitive Strengths & Weaknesses
    7.8 Lantheus
        7.8.1 Lantheus Details
        7.8.2 Lantheus Major Business
        7.8.3 Lantheus Radiopharmaceuticals for Therapeutic Product and Services
        7.8.4 Lantheus Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Lantheus Recent Developments/Updates
        7.8.6 Lantheus Competitive Strengths & Weaknesses
    7.9 Spectrum Pharmaceuticals
        7.9.1 Spectrum Pharmaceuticals Details
        7.9.2 Spectrum Pharmaceuticals Major Business
        7.9.3 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Services
        7.9.4 Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 Spectrum Pharmaceuticals Recent Developments/Updates
        7.9.6 Spectrum Pharmaceuticals Competitive Strengths & Weaknesses
    7.10 Progenics Pharmaceuticals
        7.10.1 Progenics Pharmaceuticals Details
        7.10.2 Progenics Pharmaceuticals Major Business
        7.10.3 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Services
        7.10.4 Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 Progenics Pharmaceuticals Recent Developments/Updates
        7.10.6 Progenics Pharmaceuticals Competitive Strengths & Weaknesses
    7.11 International Isotopes
        7.11.1 International Isotopes Details
        7.11.2 International Isotopes Major Business
        7.11.3 International Isotopes Radiopharmaceuticals for Therapeutic Product and Services
        7.11.4 International Isotopes Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 International Isotopes Recent Developments/Updates
        7.11.6 International Isotopes Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Radiopharmaceuticals for Therapeutic Industry Chain
    8.2 Radiopharmaceuticals for Therapeutic Upstream Analysis
    8.3 Radiopharmaceuticals for Therapeutic Midstream Analysis
    8.4 Radiopharmaceuticals for Therapeutic Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Radiopharmaceuticals for Therapeutic Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World Radiopharmaceuticals for Therapeutic Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World Radiopharmaceuticals for Therapeutic Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World Radiopharmaceuticals for Therapeutic Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World Radiopharmaceuticals for Therapeutic Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Radiopharmaceuticals for Therapeutic Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World Radiopharmaceuticals for Therapeutic Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World Radiopharmaceuticals for Therapeutic Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World Radiopharmaceuticals for Therapeutic Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key Radiopharmaceuticals for Therapeutic Players in 2022
    Table 12. World Radiopharmaceuticals for Therapeutic Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global Radiopharmaceuticals for Therapeutic Company Evaluation Quadrant
    Table 14. Head Office of Key Radiopharmaceuticals for Therapeutic Player
    Table 15. Radiopharmaceuticals for Therapeutic Market: Company Product Type Footprint
    Table 16. Radiopharmaceuticals for Therapeutic Market: Company Product Application Footprint
    Table 17. Radiopharmaceuticals for Therapeutic Mergers & Acquisitions Activity
    Table 18. United States VS China Radiopharmaceuticals for Therapeutic Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China Radiopharmaceuticals for Therapeutic Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based Radiopharmaceuticals for Therapeutic Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Radiopharmaceuticals for Therapeutic Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies Radiopharmaceuticals for Therapeutic Revenue Market Share (2018-2023)
    Table 23. China Based Radiopharmaceuticals for Therapeutic Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Radiopharmaceuticals for Therapeutic Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies Radiopharmaceuticals for Therapeutic Revenue Market Share (2018-2023)
    Table 26. Rest of World Based Radiopharmaceuticals for Therapeutic Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Radiopharmaceuticals for Therapeutic Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies Radiopharmaceuticals for Therapeutic Revenue Market Share (2018-2023)
    Table 29. World Radiopharmaceuticals for Therapeutic Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World Radiopharmaceuticals for Therapeutic Market Size by Type (2018-2023) & (USD Million)
    Table 31. World Radiopharmaceuticals for Therapeutic Market Size by Type (2024-2029) & (USD Million)
    Table 32. World Radiopharmaceuticals for Therapeutic Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World Radiopharmaceuticals for Therapeutic Market Size by Application (2018-2023) & (USD Million)
    Table 34. World Radiopharmaceuticals for Therapeutic Market Size by Application (2024-2029) & (USD Million)
    Table 35. Bayer Basic Information, Area Served and Competitors
    Table 36. Bayer Major Business
    Table 37. Bayer Radiopharmaceuticals for Therapeutic Product and Services
    Table 38. Bayer Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Bayer Recent Developments/Updates
    Table 40. Bayer Competitive Strengths & Weaknesses
    Table 41. Novartis Basic Information, Area Served and Competitors
    Table 42. Novartis Major Business
    Table 43. Novartis Radiopharmaceuticals for Therapeutic Product and Services
    Table 44. Novartis Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Novartis Recent Developments/Updates
    Table 46. Novartis Competitive Strengths & Weaknesses
    Table 47. China Isotope & Radiation Basic Information, Area Served and Competitors
    Table 48. China Isotope & Radiation Major Business
    Table 49. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Product and Services
    Table 50. China Isotope & Radiation Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. China Isotope & Radiation Recent Developments/Updates
    Table 52. China Isotope & Radiation Competitive Strengths & Weaknesses
    Table 53. Dongcheng Basic Information, Area Served and Competitors
    Table 54. Dongcheng Major Business
    Table 55. Dongcheng Radiopharmaceuticals for Therapeutic Product and Services
    Table 56. Dongcheng Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. Dongcheng Recent Developments/Updates
    Table 58. Dongcheng Competitive Strengths & Weaknesses
    Table 59. Q BioMed Basic Information, Area Served and Competitors
    Table 60. Q BioMed Major Business
    Table 61. Q BioMed Radiopharmaceuticals for Therapeutic Product and Services
    Table 62. Q BioMed Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. Q BioMed Recent Developments/Updates
    Table 64. Q BioMed Competitive Strengths & Weaknesses
    Table 65. Curium Pharmaceuticals Basic Information, Area Served and Competitors
    Table 66. Curium Pharmaceuticals Major Business
    Table 67. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Services
    Table 68. Curium Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Curium Pharmaceuticals Recent Developments/Updates
    Table 70. Curium Pharmaceuticals Competitive Strengths & Weaknesses
    Table 71. Jubilant DraxImage Basic Information, Area Served and Competitors
    Table 72. Jubilant DraxImage Major Business
    Table 73. Jubilant DraxImage Radiopharmaceuticals for Therapeutic Product and Services
    Table 74. Jubilant DraxImage Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Jubilant DraxImage Recent Developments/Updates
    Table 76. Jubilant DraxImage Competitive Strengths & Weaknesses
    Table 77. Lantheus Basic Information, Area Served and Competitors
    Table 78. Lantheus Major Business
    Table 79. Lantheus Radiopharmaceuticals for Therapeutic Product and Services
    Table 80. Lantheus Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Lantheus Recent Developments/Updates
    Table 82. Lantheus Competitive Strengths & Weaknesses
    Table 83. Spectrum Pharmaceuticals Basic Information, Area Served and Competitors
    Table 84. Spectrum Pharmaceuticals Major Business
    Table 85. Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Services
    Table 86. Spectrum Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. Spectrum Pharmaceuticals Recent Developments/Updates
    Table 88. Spectrum Pharmaceuticals Competitive Strengths & Weaknesses
    Table 89. Progenics Pharmaceuticals Basic Information, Area Served and Competitors
    Table 90. Progenics Pharmaceuticals Major Business
    Table 91. Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Product and Services
    Table 92. Progenics Pharmaceuticals Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. Progenics Pharmaceuticals Recent Developments/Updates
    Table 94. International Isotopes Basic Information, Area Served and Competitors
    Table 95. International Isotopes Major Business
    Table 96. International Isotopes Radiopharmaceuticals for Therapeutic Product and Services
    Table 97. International Isotopes Radiopharmaceuticals for Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 98. Global Key Players of Radiopharmaceuticals for Therapeutic Upstream (Raw Materials)
    Table 99. Radiopharmaceuticals for Therapeutic Typical Customers
List of Figure
    Figure 1. Radiopharmaceuticals for Therapeutic Picture
    Figure 2. World Radiopharmaceuticals for Therapeutic Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Radiopharmaceuticals for Therapeutic Total Market Size (2018-2029) & (USD Million)
    Figure 4. World Radiopharmaceuticals for Therapeutic Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World Radiopharmaceuticals for Therapeutic Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company Radiopharmaceuticals for Therapeutic Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company Radiopharmaceuticals for Therapeutic Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company Radiopharmaceuticals for Therapeutic Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company Radiopharmaceuticals for Therapeutic Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company Radiopharmaceuticals for Therapeutic Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company Radiopharmaceuticals for Therapeutic Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company Radiopharmaceuticals for Therapeutic Revenue (2018-2029) & (USD Million)
    Figure 13. Radiopharmaceuticals for Therapeutic Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 16. World Radiopharmaceuticals for Therapeutic Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 18. China Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 23. India Radiopharmaceuticals for Therapeutic Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of Radiopharmaceuticals for Therapeutic by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Radiopharmaceuticals for Therapeutic Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Radiopharmaceuticals for Therapeutic Markets in 2022
    Figure 27. United States VS China: Radiopharmaceuticals for Therapeutic Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Radiopharmaceuticals for Therapeutic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World Radiopharmaceuticals for Therapeutic Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World Radiopharmaceuticals for Therapeutic Market Size Market Share by Type in 2022
    Figure 31. Radium-223
    Figure 32. Lutetium-177
    Figure 33. Iodine-131
    Figure 34. Other
    Figure 35. World Radiopharmaceuticals for Therapeutic Market Size Market Share by Type (2018-2029)
    Figure 36. World Radiopharmaceuticals for Therapeutic Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World Radiopharmaceuticals for Therapeutic Market Size Market Share by Application in 2022
    Figure 38. Thyroid
    Figure 39. Bone Metastasis
    Figure 40. Lymphoma
    Figure 41. Other
    Figure 42. Radiopharmaceuticals for Therapeutic Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source